QuidelOrtho Corp

QDELNASDAQ · USD
14.09USD0.00 (+0.43%)
655

QuidelOrtho Corp (QDEL) Option Chain

QuidelOrtho Corp trades at $14.09, up 0.43%, with an IV Rank of 97.62%. This is high versus the past year, and the company carries a market cap of $966M in the Medical Devices industry. On the Nov 20, 2026 chain, the at the money $15.00 strike shows calls at $0.60 / $0.95 and puts at $1.65 / $2.70, both carrying about $1.02 of extrinsic value and a roughly 50% probability of expiring out of the money. Volume is heaviest on the $15.00 calls, at 21 contracts, and the $12.50 puts, at 57, as of Nov 3, 2026.

Read more

Tracking the QDEL option chain helps you see every strike and expiry on QuidelOrtho Corp in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of QDEL options activity at a glance. Use our scanner to monitor the QDEL option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For QDEL stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where QDEL options are being actively traded, and where they are not.

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
11.35320-0.064.091.956.1010.00-27.330.102.500.001.30011688.65
38.7514600.391.590.853.1012.50-9.160.451.000.000.73571161.25
68.00622210.780.000.600.9515.00+9.011.652.700.911.260032.00
86.5430100.330.000.200.4517.50+27.182.004.903.410.040013.46
95.12202.300.00—2.3020.00+45.354.308.505.910.49004.88

As of Nov 3, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV Rank97.62% High
  • Market cap (M$)966
  • 52 weeks high-60.40%
  • 52 weeks low42.04%
  • Analyst recommendationHold
    3.25
  • Target price$14.67
    4.12% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-03
  • P/E—
  • Future P/E9.87
  • EPS (ttm)-15.41
  • EPS growth next 5 years-4.59%

As of Nov 3, 2026